SANOFI SA Reports Fourth Quarter Earnings Results for Fiscal Year 2022 on February 3, 2023.
March 6, 2023
Earnings report
On February 3, 2023, SANOFI SA ($BER:SNW) reported its earnings results for the fourth quarter of Fiscal Year 2022, which ended on December 31, 2022. Total revenue for the quarter was EUR 1.5 billion, representing an increase of 29.2% compared to the corresponding period in the previous year. SANOFI SA also achieved a net income of EUR 11.5 billion, which is a 10.0% year-over-year growth from the same quarter of the previous year. This growth in revenue and net income is an indicator of the company’s strong financial performance during this period.
Share Price
At the opening of the stock trading on Friday, the stock opened at €86.0 and ended the trading day at the same price, representing a 3.2% decrease from its previous closing price of 88.9. The company’s fourth quarter earnings are seen as signaling potential areas of strength for SANOFI SA, as well as potential weak points that will need to be addressed in the upcoming quarters. Investors are watching how well the company’s performance will improve in the next fiscal year with cautious optimism. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Sanofi Sa. More…
Total Revenues | Net Income | Net Margin |
45.39k | 6.72k | 20.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Sanofi Sa. More…
Operations | Investing | Financing |
3.83k | -7.3k | -7.06k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Sanofi Sa. More…
Total Assets | Total Liabilities | Book Value Per Share |
124.58k | 51.07k | 58.32 |
Key Ratios Snapshot
Some of the financial key ratios for Sanofi Sa are shown below. More…
3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
6.4% | 18.0% | 19.2% |
FCF Margin | ROE | ROA |
6.3% | 7.6% | 4.4% |
Analysis
GoodWhale has analyzed SANOFI SA’s financials, and our Star Chart shows that the company has a very high health score of 8/10 with regard to its cashflows and debt. This suggests that the company is capable of riding out any crisis without the risk of bankruptcy. What’s more, it is classified as a ‘gorilla’, a type of company that is characterized by its strong competitive advantage, high revenues and earnings growth. Such a company may be of interest to investors looking for stability and long-term income, as SANOFI SA is strong in dividend and profitability, and medium in asset and growth. Its strong competitive position also means that it is less likely to suffer from competition-related upheaval. As a result, investors may be drawn to this company as they expect it to generate attractive returns over the long run. More…
Summary
Net income for the quarter also rose 10.0% to EUR 11.5 billion. Despite the positive news, the stock price moved down the same day, suggesting investors may be concerned about growth in the company’s performance. Nevertheless, with strong revenue and net income increases, SANOFI SA may continue to see positive returns in the near future.
Recent Posts